businesspress24.com - GENEWIZ, Inc. Announces CLIA Certification
 

GENEWIZ, Inc. Announces CLIA Certification

ID: 1125009

(firmenpresse) - SOUTH PLAINFIELD, NJ -- (Marketwire) -- 06/18/12 -- , leading global DNA service provider, received Clinical Laboratory Improvement Amendments (CLIA) Licensure and Certificate of Registration from the State of New Jersey.

CLIA certification marks the milestone expansion of GENEWIZ solutions to include clinical genomic testing, thus contributing to advancements in personalized medicine. Beyond the Kras and EGFR tests, GENEWIZ intends to continue development of additional CLIA-certified assays through utilization of both traditional platforms and new cutting edge technologies, such as .

"With CLIA registration, GENEWIZ now has the capacity to provide comprehensive solutions for clients working in clinical environments," stated Conrad Leung, Vice President, GENEWIZ, Inc. "We are committed to providing clinical researchers, physicians, and patients with genomic testing results that ultimately lead to better diagnoses and more effective treatments."

To support the growth of clinical genomic testing, GENEWIZ recently expanded laboratory operations at their Global Headquarters in South Plainfield, NJ to include a clean suite dedicated to the processing of clinical and pre-clinical samples. This laboratory enables GENEWIZ to provide expanded services in the areas of biologic drug and cell bank characterization testing, clinical trial investigations, and clinical diagnostic testing.

is a global contract research organization (CRO) specializing in , including , , , , , and services. GENEWIZ leads the industry in outsourcing partnerships with pharmaceutical, biotechnology, clinical, academic, and government institutions.

Headquartered in South Plainfield, NJ, GENEWIZ, Inc. is a privately-held global enterprise with locations in Boston, MA; San Diego, CA; Washington, DC Metro; Research Triangle Park, NC; and Seattle, WA. International locations include Beijing, China; Suzhou, China; and London, United Kingdom.





Amy Liao, Ph.D.
COO & President


GENEWIZ, Inc.
115 Corporate Boulevard
South Plainfield, NJ 07080
1-877-GENEWIZ (436-3949)


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Bio-Matrix Scientific Group Announces David Audley, the Founder of International Cellular Medicine Society, Has Joined the Advisory Board of Its Regen BioPharma Subsidiary
Anatomy of a Drug Manufacturing Plant (Last in a Three-Part Series Examining the Financial Impact of New Plant Construction), an Industrial Info News Alert
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 18.06.2012 - 04:00 Uhr
Sprache: Deutsch
News-ID 1125009
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

SOUTH PLAINFIELD, NJ


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 148 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"GENEWIZ, Inc. Announces CLIA Certification
"
steht unter der journalistisch-redaktionellen Verantwortung von

GENEWIZ, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von GENEWIZ, Inc.



 

Who is online

All members: 10 567
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 69


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.